Vascular endothelial growth factor (VEGF)-D and VEGF-A differentially regulate KDR-mediated signaling and biological function in vascular endothelial cells

被引:71
作者
Jia, HY
Bagherzadeh, A
Bicknell, R
Duchen, MR
Liu, D
Zachary, I
机构
[1] UCL, Rayne Inst, Dept Med, London WC1E 6JJ, England
[2] Univ Oxford, Inst Mol Med, Canc Res UK, Oxford, England
[3] UCL, Dept Physiol, London WC1E 6BT, England
关键词
D O I
10.1074/jbc.M401538200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular endothelial growth factor (VEGF)-D binds to VEGF receptors (VEGFR) VEGFR2/KDR and VEGFR3/Flt4, but the signaling mechanisms mediating its biological activities in endothelial cells are poorly understood. Here we investigated the mechanism of action of VEGF-D, and we compared the signaling pathways and biological responses induced by VEGF-D and VEGF-A in endothelial cells. VEGF-D induced KDR and phospholipase C-gamma tyrosine phosphorylation more slowly and less effectively than VEGF-A at early times but had a more sustained effect and was as effective as VEGF-A after 60 min. VEGF-D activated extracellular signal-regulated protein kinases 1 and 2 with similar efficacy but slower kinetics compared with VEGF-A, and this effect was blocked by inhibitors of protein kinase C and mitogen-activated protein kinase kinase. In contrast to VEGF-A, VEGF-D weakly stimulated prostacyclin production and gene expression, had little effect on cell proliferation, and stimulated a smaller and more transient increase in intracellular [Ca(2+)]. VEGF-D induced strong but more transient phosphatidylinositol 3-kinase (PI3K)-mediated Akt activation and increased PI3K-dependent endothelial nitric-oxide synthase phosphorylation and cell survival more weakly. VEGF-D stimulated chemotaxis via a PI3K/Akt- and endothelial nitric-oxide synthase-dependent pathway, enhanced protein kinase C- and PI3K-dependent endothelial tubulogenesis, and stimulated angiogenesis in a mouse sponge implant model less effectively than VEGF-A. VEGF-D-induced signaling and biological effects were blocked by the KDR inhibitor SU5614. The finding that differential KDR activation by VEGF-A and VEGF-D has distinct consequences for endothelial signaling and function has important implications for understanding how multiple ligands for the same VEGF receptors can generate ligand-specific biological responses.
引用
收藏
页码:36148 / 36157
页数:10
相关论文
共 50 条
  • [21] Complexity in the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF)-receptors signaling
    Debabrata Mukhopadhyay
    Huiyan Zeng
    Resham Bhattacharya
    Molecular and Cellular Biochemistry, 2004, 264 : 51 - 61
  • [22] Complexity in the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF)-receptors signaling
    Mukhopadhyay, D
    Zeng, HY
    Bhattacharya, R
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2004, 264 (1-2) : 51 - 61
  • [23] Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF)
    Stiver, SI
    Dvorak, HF
    JOURNAL OF CLINICAL LIGAND ASSAY, 2000, 23 (03): : 193 - 205
  • [24] Tubulogenesis by microvascular endothelial cells is mediated by vascular endothelial growth factor (VEGF) in renal cell carcinoma
    Nakagawa, M
    Emoto, A
    Hanada, T
    Nasu, N
    Nomura, Y
    BRITISH JOURNAL OF UROLOGY, 1997, 79 (05): : 681 - 687
  • [25] Angiogenesis mediated by metabolites is dependent on vascular endothelial growth factor (VEGF)
    P.A. Burns
    D.J. Wilson
    Angiogenesis, 2003, 6 (1) : 73 - 77
  • [26] Is superoxide anion a mediator of vascular endothelial growth factor (VEGF) angiogenic function in retinal endothelial cells?
    El-Remessy, AB
    Tsai, NT
    Caldwell, RB
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U77 - U77
  • [27] Dual signaling pathways regulate vascular endothelial growth factor (VEGF) induction of eNOS in glomerular endothelial (G Endo) cells.
    Chen, X
    Akis, N
    Choudhury, GG
    Madaio, M
    Kasinath, BS
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (01) : S320 - S320
  • [28] Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells
    Frick, M
    Dulak, J
    Cisowski, J
    Józkowicz, A
    Zwick, R
    Alber, H
    Dichtl, W
    Schwarzacher, SP
    Pachinger, O
    Weidinger, F
    ATHEROSCLEROSIS, 2003, 170 (02) : 229 - 236
  • [29] Vascular endothelial growth factor (VEGF-A) in Fabry disease correlation with the cutaneous and the systemic manifestations with vascular involvement
    Zampetti, Anna
    Gnarra, Maria
    Giurdanella, Federica
    Borsini, Walter
    Antuzzi, Daniela
    Smaldone, Costantino
    Pieroni, Maurizio
    Cadeddu, Chiara
    de Waure, Chiara
    Ferri, Lorenzo
    Morrone, Amelia
    Feliciani, Claudio
    MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : S100 - S101
  • [30] Plasma vascular endothelial growth factor-A (VEGF-A) and VEGF-A gene polymorphism are associated with hydrocele development in lymphatic filariasis
    Debrah, Alexander Yaw
    Mand, Sabine
    Toliat, Mohammad Reza
    Marfo-Debrekyei, Yeboah
    Batsa, Linda
    Nuejrnberg, Peter
    Lawson, Bernard
    Adjei, Ohene
    Hoerauf, Achim
    Pfarr, Kenneth
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (04) : 601 - 608